Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

被引:0
|
作者
Ronald E. Myers
Amy E. Leader
Jean Hoffman Censits
Edouard J. Trabulsi
Scott W. Keith
Anett M. Petrich
Anna M. Quinn
Robert B. Den
Mark D. Hurwitz
Costas D. Lallas
Sarah E. Hegarty
Adam P. Dicker
Charnita M. Zeigler-Johnson
Veda N. Giri
Hasan Ayaz
Leonard G. Gomella
机构
[1] Sidney Kimmel Medical College,Division of Population Science, Department of Medical Oncology
[2] Thomas Jefferson University,Department of Urology
[3] Sidney Kimmel Medical College,Department of Pharmacology and Experimental Therapeutics
[4] Thomas Jefferson University,Department of Radiation Oncology
[5] Sidney Kimmel Medical College,School of Biomedical Engineering, Science and Health Systems
[6] Thomas Jefferson University,undefined
[7] Sidney Kimmel Medical College,undefined
[8] Thomas Jefferson University,undefined
[9] Drexel University,undefined
来源
Journal of Cancer Education | 2018年 / 33卷
关键词
Prostate cancer; Active surveillance; Shared decision making; Decision support interventions;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to explore the effects of a decision support intervention (DSI) and shared decision making (SDM) on knowledge, perceptions about treatment, and treatment choice among men diagnosed with localized low-risk prostate cancer (PCa). At a multidisciplinary clinic visit, 30 consenting men with localized low-risk PCa completed a baseline survey, had a nurse-mediated online DS session to clarify preference for active surveillance (AS) or active treatment (AT), and met with clinicians for SDM. Participants also completed a follow-up survey at 30 days. We assessed change in treatment knowledge, decisional conflict, and perceptions and identified predictors of AS. At follow-up, participants exhibited increased knowledge (p < 0.001), decreased decisional conflict (p < 0.001), and more favorable perceptions of AS (p = 0.001). Furthermore, 25 of the 30 participants (83 %) initiated AS. Increased family and clinician support predicted this choice (p < 0.001). DSI/SDM prepared patients to make an informed decision. Perceived support of the decision facilitated patient choice of AS.
引用
收藏
页码:180 / 185
页数:5
相关论文
共 50 条
  • [31] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [32] Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital
    Osterberg, E. Charles
    Palmer, Nynikka R. A.
    Harris, Catherine R.
    Murphy, Gregory P.
    Blaschko, Sarah D.
    Chu, Carissa
    Allen, Isabel E.
    Cooperberg, Matthew R.
    Carroll, Peter R.
    Breyer, Benjamin N.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (11) : 663.e9 - 663.e14
  • [33] Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance
    Davison, Barbara Joyce
    Breckon, Erin
    PATIENT EDUCATION AND COUNSELING, 2012, 87 (03) : 369 - 374
  • [34] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino, Sebastiano
    Privitera, Salvatore
    Favilla, Vincenzo
    Cantiello, Francesco
    Manno, Stefano
    Cicione, Antonio
    Damiano, Rocco
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 958 - 963
  • [35] Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?
    Xu, Ming
    Zhang, Li
    Liang, Chaozhao
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (08) : 1287 - 1289
  • [36] Whole-gland ablation therapy versus active surveillance for low-risk prostate cancer: a prospective study
    Enikeev, Dmitry
    Taratkin, Mark
    Amosov, Alexander
    Rivas, Juan Gomez
    Podoinitsin, Alexei
    Potoldykova, Natalya
    Karageziyan, Marina
    Glybochko, Petr
    Barret, Eric
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 127 - 133
  • [37] Active surveillance for low-risk prostate cancer - in pursuit of a standardized protocol
    Sosnowski, Roman
    Kamecki, Hubert
    Daneshmand, Siamak
    Rudzinski, Jan K.
    Bjurlin, Marc A.
    Giganti, Francesco
    Roobol, Monique J.
    Klotz, Laurence
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 123 - 126
  • [38] Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?
    Ming Xu
    Li Zhang
    Chaozhao Liang
    International Urology and Nephrology, 2016, 48 : 1287 - 1289
  • [39] A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer
    Sawka, Anna M.
    Ghai, Sangeet
    Yoannidis, Tom
    Rotstein, Lorne
    Gullane, Patrick J.
    Gilbert, Ralph W.
    Pasternak, Jesse D.
    Brown, Dale H.
    Eskander, Antoine
    de Almeida, John R.
    Irish, Jonathan C.
    Higgins, Kevin
    Enepekides, Danny J.
    Monteiro, Eric
    Banerjee, Avik
    Shah, Manish
    Gooden, Everton
    Zahedi, Afshan
    Korman, Mark
    Ezzat, Shereen
    Jones, Jennifer M.
    Rac, Valeria E.
    Tomlinson, George
    Stanimirovic, Aleksandra
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2020, 30 (07) : 999 - 1007
  • [40] Shared Decision Making During Labor and Birth Among Low-Risk, Active-Duty Women in the US Military
    Iobst, Stacey
    Maj, Angela Phillips
    Wilson, Candy
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2021, 50 (05): : S32 - S32